Understanding Metabolic Medicines: More Myths About Ozempic, Mounjaro, and Wegovy

Listener questions answered! Dr. Emily Cooper, Andrea Taylor, and Mark Wright are back with more information on the myths about Ozempic, Mounjaro, Wegovy, and other GLP-1 mimetics on this episode of Fat Science. They answer questions from the Fat Science audience about pharmaceutical ties and long-term medication use, debunk myths about "gut paralysis" and stomach explosions, and address the diet mentality that misconstrues these treatments as fleeting solutions to weight loss. If you're grappling with metabolic health or curious about these treatments, this episode is your must-listen guide.   Resources from the episode: Learn more about Fat Science here. Connect with Dr. Emily Cooper on LinkedIn. Connect with Andrea Taylor on LinkedIn. Connect with Mark Wright on LinkedIn.   Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go (and stay!) away. In each episode, we share little-known facts and personal experiences to dispel misconceptions, reduce stigma, and instill hope. Fat Science is committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.  If you have a show idea, feedback, or just want to connect, email Mark Wright at [email protected].